1.26
price up icon2.44%   0.03
after-market Dopo l'orario di chiusura: 1.28 0.02 +1.59%
loading
Precedente Chiudi:
$1.23
Aprire:
$1.27
Volume 24 ore:
1.51M
Relative Volume:
2.03
Capitalizzazione di mercato:
$3.06M
Reddito:
$212.10K
Utile/perdita netta:
$-40.19M
Rapporto P/E:
-0.000237
EPS:
-5313.2836
Flusso di cassa netto:
$-13.92M
1 W Prestazione:
+4.13%
1M Prestazione:
-5.26%
6M Prestazione:
-95.70%
1 anno Prestazione:
-99.99%
Intervallo 1D:
Value
$1.23
$1.31
Intervallo di 1 settimana:
Value
$1.16
$1.31
Portata 52W:
Value
$1.05
$21,400.00

Aditxt Inc Stock (ADTX) Company Profile

Name
Nome
Aditxt Inc
Name
Telefono
909-488-0844
Name
Indirizzo
737 N. FIFTH STREET, SUITE 200, RICHMOND
Name
Dipendente
26
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-18
Name
Ultimi documenti SEC
Name
ADTX's Discussions on Twitter

Confronta ADTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ADTX
Aditxt Inc
1.26 2.99M 212.10K -40.19M -13.92M -5,313.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Aditxt Inc Borsa (ADTX) Ultime notizie

pulisher
Jul 24, 2025

Aditxt CEO Highlights Immunotherapy at Investor Event - TipRanks

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Aditxt Inc. stock pricePowerful profit generation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Aditxt Inc. stockExplosive capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Aditxt Inc. a good long term investmentSuperior risk-adjusted returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Aditxt Inc. Stock Analysis and ForecastRapidly expanding wealth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Aditxt to Present at Wall Street Reporter’s Next Super Stock Livestream Today July 22, 2025, at 1 p.m. ET - Business Wire

Jul 22, 2025
pulisher
Jul 21, 2025

Aditxt Showcases Pearsanta’s Diagnostic Advancements - TipRanks

Jul 21, 2025
pulisher
Jul 15, 2025

Phexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Phexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy - Benzinga

Jul 15, 2025
pulisher
Jul 13, 2025

Aditxt CEO Discusses Strategic Initiatives at Livestream - MSN

Jul 13, 2025
pulisher
Jul 08, 2025

Aditxt unveils bitcoin-backed strategy to support biotech ventures - Investing.com Australia

Jul 08, 2025
pulisher
Jul 07, 2025

Aditxt launches Bitcoin treasury strategy to fund biotech ventures - Investing.com Australia

Jul 07, 2025
pulisher
Jul 07, 2025

Aditxt launches Bitcoin treasury strategy to fund biotech ventures By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Aditxt, Inc. Unveils bitXbio - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Aditxt unveils bitcoin-backed strategy to support biotech ventures By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Aditxt Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization - The Globe and Mail

Jul 07, 2025
pulisher
Jul 02, 2025

Evofem Biosciences Enters Securities Purchase Agreement - TipRanks

Jul 02, 2025
pulisher
Jul 02, 2025

Aditxt CEO Discusses Strategic Growth at Livestream Event - The Globe and Mail

Jul 02, 2025
pulisher
Jul 01, 2025

Adtx - AInvest

Jul 01, 2025
pulisher
Jun 26, 2025

Aditxt to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ET - Bluefield Daily Telegraph

Jun 26, 2025
pulisher
Jun 25, 2025

Appili Therapeutics: Navigating Biodefense Challenges Amid Strategic Shifts - AInvest

Jun 25, 2025
pulisher
Jun 21, 2025

Aditxt Inc. Integrates Bitcoin into Treasury Strategy with 302 Mentions in SEC Filing - AInvest

Jun 21, 2025
pulisher
Jun 20, 2025

Aditxt Incorporates Bitcoin Focused Digital Asset Strategy - AInvest

Jun 20, 2025
pulisher
Jun 10, 2025

Evofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board - citybiz

Jun 10, 2025
pulisher
Jun 10, 2025

Aditxt Inc. Strengthens Board with Appointment of Evofem CEO Saundra Pelletier - citybuzz -

Jun 10, 2025
pulisher
Jun 09, 2025

Aditxt names Evofem CEO to its board, eyes women’s health market By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Aditxt names Evofem CEO to its board, eyes women’s health market - Investing.com India

Jun 09, 2025
pulisher
Jun 09, 2025

Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board Of Directors - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Aditxt (ADTX) Welcomes Saundra Pelletier to Its Board | ADTX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors | ADTX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Evofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board of Directors - Business Wire

Jun 09, 2025
pulisher
Jun 05, 2025

Saundra Pelletier, Evofem Biosciences' CEO, Dr. Friedrich Kapp, - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Saundra Pelletier, Evofem Biosciences' CEO, Dr. Friedrich Kapp, Co-CEO Of Adimune, And Chris Mitton, President Of Pearsanta, Will Join Aditxt Weekly Update On June 6 - MarketScreener

Jun 05, 2025

Aditxt Inc Azioni (ADTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):